BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Kyorin Pharmaceutical Co., Ltd. 

5, Kanda Surugadai 2-chome
Chiyoda-ku
Tokyo    101  Japan
Phone: Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Pharmaceutical

Segment
Pharmaceuticals





 Company News
SkyePharma Inc. (SKYE)’s Partner Kyorin Pharmaceutical Co., Ltd. Launches 120-Puff Version Of Flutiform In Japan 12/1/2014 2:35:16 PM
Eisai Company, Ltd. (ESALY.PK) And Kyorin Pharmaceutical Co., Ltd. Enter Into Agreement Concerning Compound Library Use For The Development Of New Antibacterial Agents 9/19/2014 7:32:52 AM
Kyorin Pharmaceutical Co., Ltd. and BioLeap Enter Research Collaboration 1/9/2012 6:30:16 AM
Kyorin Pharmaceutical Co., Ltd. and Eisai Company, Ltd. (ESALY.PK) Sign License Agreement for Development and Marketing of Uritos(R) Tablets in China, India, Sri Lanka and ASEAN Countries 9/29/2009 10:31:59 AM
Skyepharma PLC (SKYE) Announces Exclusive License Agreement with Kyorin Pharmaceutical Co., Ltd. for Development and Distribution of Flutiform(TM) in Japan 4/22/2008 10:20:58 AM
Bristol-Myers Squibb Company (BMY) To Stop Sale, Manufacture Of Antibiotic Tequin 5/2/2006 11:15:39 AM
Kyorin Pharmaceutical Co., Ltd. To Reorganize Its Group Businesses In October 4/21/2006 10:33:53 AM
ActivX Biosciences, Inc./Kyorin Pharmaceutical Co., Ltd. Begins First U.S. Phase I Study For Novel Anti-Diabetic Drug 3/15/2006 10:19:54 AM
Kyorin Pharmaceutical Co., Ltd. Licenses Immunosuppressant Drug To Novartis Corporation (NVS) 2/16/2006 10:23:43 AM
Dainippon Pharmaceutical And Kyorin Pharmaceutical Co., Ltd. To Collaborate In Development Of Drug Candidate For Diabetic Complication10/19/2005 5:13:06 PM
123